Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mario Castro, MD
University of Kansas School of Medicine 3901 Rainbow Blvd. Kansas City, KS 66160, USA
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Calgary, Alberta, Canada
- Research Site
Aalborg, Denmark
- Research Site
Aarhus N, Denmark
- Research Site
Copenhagen, Denmark
- Research Site
Hvidovre, Denmark
- Research Site
Næstved, Denmark
- Research Site
Odense C, Denmark
- Research Site
Vejle, Denmark
- Research Site
Gothenburg, Sweden
- Research Site
Lund, Sweden
- Research Site
Cambridge, United Kingdom
- Research Site
Headington, United Kingdom
- Research Site
Leicester, United Kingdom
- Research Site
Liverpool, United Kingdom
- Research Site
London, United Kingdom
- Research Site
Wythenshawe, United Kingdom
- Research Site
Birmingham, Alabama, United States
- Research Site
Los Angeles, California, United States
- Research Site
Jacksonville, Florida, United States
- Research Site
Miami, Florida, United States
- Research Site
Snellville, Georgia, United States
- Research Site
Indianapolis, Indiana, United States
- Research Site
Iowa City, Iowa, United States
- Research Site
Kansas City, Kansas, United States
- Research Site
Ann Arbor, Michigan, United States
- Research Site
Bloomfield Hills, Michigan, United States
- Research Site
Rochester, Minnesota, United States
- Research Site
St Louis, Missouri, United States
- Research Site
Maspeth, New York, United States
- Research Site
New Bern, North Carolina, United States
- Research Site
Winston-Salem, North Carolina, United States
- Research Site
Pittsburgh, Pennsylvania, United States
- Research Site
Galveston, Texas, United States
- Research Site
Lewisville, Texas, United States
- Research Site
Mansfield, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Oct 2019
- Primary completion
- 19 Oct 2026
- Completion
- 19 Oct 2026
- Last update posted
- 29 Jun 2026
- Registered enrollment
- 75
- Registry id
- NCT03953300
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.